Text Size

Antiviral response in vernal keratoconjunctivitis may be protective against COVID-19

Leonardi A., Rosani U., Cavarzeran F., Daull P., Garrigue J.-S., Paola B.

  • 2021
  • Allergy: European Journal of Allergy and Clinical Immunology
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Disease understanding (epidemiology, diagnosis, QoL, Biomarkers…)

  • Affiliations

    Department of Neuroscience, Ophthalmology Unit, University of Padua, Padova, Italy; Department of Biology, University of Padova, Padova, Italy; Santen SAS, Evry, France; Department of Molecular Medicine, Histology Unit, University of Padova, Padova, Italy

Related Publications

Trans-eyelid distribution of epinastine to the conjunctiva following eyelid application in rabbits

Mochizuki T.; Hata T.; Mori N.; Yamazaki T.; Noto T.; Mano H.

Burden of Vernal Keratoconjunctivitis in the United States: A Retrospective Claims Database Analysis

Koo E.B.; Yu T.M.; Layton A.J.; Babineaux S.; Fung S.

Review of clinical outcomes of a cationic emulsion tear substitute in patients with dry eye disease

Labetoulle M, Garhöfer G, Ismail D, Garrigue JS, Amrane M, Guillon M, Aragona P, Baudouin C.

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022